Ionis Pharmaceuticals, Inc. Common Stock (NASDAQ: IONS) last traded at $59.74, up 1.67% on the session. The quote above updates while this page is open; the figures below are drawn from Ionis Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Ionis Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker IONS. Its market capitalisation is $9.93 billion.
Valuation measures for Ionis Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.93B |
|---|---|
| Enterprise value | $12.13B |
| Price / sales | 11.36 |
| Price / book | 22.58 |
| Beta | 0.21 |
Trailing-twelve-month figures tagged in Ionis Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $874.09M |
|---|---|
| Net income (TTM) | -$565.17M |
| EPS (TTM) | -$3.46 |
| Operating margin | -68.00% |
| Return on equity | -128.53% |
| Cash | $350.06M |
Range and volume for IONS over the past 52 weeks.
| 52-week high | $86.74 |
|---|---|
| 52-week low | $41.71 |
| Volume | 2.63M |
| Average volume | 2.89M |
| Previous close | $58.76 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.